Chemours Co (CC)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Chemours Co.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 6 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 16.60 $ — 35% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/03/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
Quality & Screener
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Growth Score
3 of 10 Weak growthTen checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years -5.3% failed
- More than 10% revenue growth is expected for the coming year 5.6% failed
- Share count grows by less than 3% a year -1.7% passed
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 1.3% failed
- Gross margin at 40% or higher and without meaningful erosion 15.5% failed
- Goodwill from acquisitions does not grow faster than revenue 0.6% passed
- Net debt below twice EBITDA 11.8 x EBITDA failed
- Operating cash flow covers the profits of the last three years 725 m passed
- Return on capital at 15% or higher, or up versus two years ago -0.1% failed
- Insiders hold at least 10% or are net buyers 0.4% failed
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Analysts & Price Target
The price target sits 48.6% above the current price.
- Consensus
- Sell
- Analyst Ratings
- 10
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 1.28 | 0.55 – 1.65 | 6,046 | 34.3% | 9 |
| 12/31/2027 | 2.23 | 1.90 – 2.67 | 6,383 | 75.0% | 9 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Next Reporting Date
- Expected Earnings per Share
- 0.43 $
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | -0.05 | – | 1,394 | -1.30 | -0.60 | 138 | 29 |
| 2025: Q1 | -0.03 | -107.40 | 1,368 | 0.40 | -0.30 | -112 | -196 |
| 2025: Q2 | -2.54 | -734.50 | 1,615 | 3.90 | -23.60 | 93 | 50 |
| 2025: Q3 | 0.40 | – | 1,495 | -0.40 | 4.00 | 146 | 105 |
| 2025: Q4 | -0.41 | – | 1,330 | -4.60 | -4.60 | 137 | 92 |
| 2026: Q1 | -0.19 | – | 1,381 | 1.00 | -2.10 | -44 | -93 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2016 | 5,400 | 96 | 7 | 0.04 | 594 | 100 | 6,060 |
| 2017 | 6,183 | 1,072 | 746 | 3.91 | 639 | 860 | 7,293 |
| 2018 | 6,638 | 1,232 | 995 | 5.45 | 1,140 | 1,014 | 7,362 |
| 2019 | 5,526 | 447 | -52 | -0.32 | 650 | 689 | 7,258 |
| 2020 | 4,969 | 448 | 219 | 1.32 | 807 | 813 | 7,082 |
| 2021 | 6,345 | 674 | 608 | 3.60 | 820 | 1,081 | 7,550 |
| 2022 | 6,831 | 786 | 578 | 3.65 | 754 | 1,107 | 7,640 |
| 2023 | 6,078 | -123 | -238 | -1.60 | 556 | 737 | 8,251 |
| 2024 | 5,782 | 443 | 86 | 0.57 | -633 | 604 | 7,515 |
| 2025 | 5,808 | -5 | -386 | -2.56 | 264 | 250 | 7,382 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
About the Company
| CEO Insider Trades (12 Mo.) | buying own stock |
|---|---|
| Employees | 5,700 |
| Headquarters | Wilmington, DE |
| Address | 1007 Market Street, 19801 Wilmington, United States |
| Phone | 302 773 1000 |
| Website | chemours.com |
| IPO Date | 1. Jul 2015 |
| ISIN | US1638511089 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Denise M. Dignam | President, CEO & Director | 1966 |
| Shane W. Hostetter CPA | Senior VP & CFO | 1981 |
| Kristine M. Wellman | Senior VP, General Counsel & Company Secretary | 1970 |
| Gerardo Familiar Calderon | President of Advanced Performance Materials | 1977 |
| Joseph T. Martinko | President of Thermal & Specialized Solutions | 1969 |
| David A. Will | Controller & Chief Accounting Officer | 1985 |
| Brandon Ontjes | Vice President of Investor Relations | – |
| Matthew J. Conti | Chief Human Resources Officer | – |
| Aditya Beri | Interim President of Titanium Technologies & Chemical Solutions Business | – |
| Diane Iuliano Picho | Chief Enterprise Enablement Officer | 1962 |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.